These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3520204)
21. Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B. Kumada H; Ikeda K; Yoshida A; Seto S; Tsukada T; Kojima M; Suzuki H; Mayumi M Jpn J Med; 1987 May; 26(2):217-22. PubMed ID: 3626161 [TBL] [Abstract][Full Text] [Related]
22. Acute exacerbation in chronic type B hepatitis: comparison between HBeAg and antibody-positive patients. Liaw YF; Tai DI; Chu CM; Pao CC; Chen TJ Hepatology; 1987; 7(1):20-3. PubMed ID: 2433203 [TBL] [Abstract][Full Text] [Related]
23. [A clinicopathological study of seroconversion from HBeAg to anti-HBe in patients with chronic hepatitis B]. Liu JH; Yan JC; Wang HP Zhonghua Nei Ke Za Zhi; 1988 Oct; 27(10):621-3, 653. PubMed ID: 3229186 [No Abstract] [Full Text] [Related]
24. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B. Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369 [TBL] [Abstract][Full Text] [Related]
25. The HBe antigen-antibody system and its relationship to clinical and laboratory findings in 100 chronic HBsAg carriers in Great Britain. Viola LA; Barrison IG; Coleman JC; Paradinas FJ; Murray-Lyon IM J Med Virol; 1981; 8(3):169-75. PubMed ID: 7328422 [TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of 60 patients with chronic hepatitis B. I. Seroconversion in the hepatitis B e-system, frequency of delta infection and histological outcome. Lindh G; Weiland O; Svedmyr A; Glaumann H; Hansson BG Liver; 1986 Feb; 6(1):7-12. PubMed ID: 3713454 [TBL] [Abstract][Full Text] [Related]
27. Distribution of hepatitis B e antigen (HBeAg) and anti-HBe in carriers with different levels of HBsAg. Nath N; Fang CT; Fields HA; Doto IL; Maynard JE J Med Virol; 1980; 6(2):179-84. PubMed ID: 7241093 [TBL] [Abstract][Full Text] [Related]
28. Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model. Takano S; Omata M; Yokosuka O; Imazeki F; Ohto M Dig Dis Sci; 1992 Nov; 37(11):1633-43. PubMed ID: 1425062 [TBL] [Abstract][Full Text] [Related]
29. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers. Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of a new radioimmunoassay for detecting hepatitis B e antigen and its antibody. Löfgren B; Nordenfelt E J Med Virol; 1980; 5(4):323-30. PubMed ID: 7229621 [TBL] [Abstract][Full Text] [Related]
31. Hepatitis B e antigen and antibody in asymptomatic Chinese with hepatitis B surface antigenemia in Taiwan. Sung JL; Chen DS; Lai MY; Wang TH; Wang CY; Yü JY; Lee CY Gastroenterol Jpn; 1982; 17(4):341-6. PubMed ID: 7141198 [TBL] [Abstract][Full Text] [Related]
32. [Seven-year follow-up studies on asymptomatic HBs Ag carriers]. Nishida S; Tada R; Nishiwaki T; Takahashi R; Yanagawa S; Mitamura K Sangyo Igaku; 1982 May; 24(3):253-64. PubMed ID: 7143797 [TBL] [Abstract][Full Text] [Related]
33. IgM antibody to hepatitis B core antigen in children with chronic type B hepatitis. Bortolotti F; Bertaggia A; Rude L; Armigliato M; Crivellaro C; Alberti A; Pornaro E; Realdi G Eur J Pediatr; 1987 Jul; 146(4):394-7. PubMed ID: 3653136 [TBL] [Abstract][Full Text] [Related]
34. The role of delta superinfection in acute exacerbations of chronic type B hepatitis. Chu CM; Farci P; Liaw YF; Balestrieri A; Thomas HC Liver; 1986 Feb; 6(1):26-9. PubMed ID: 3713452 [TBL] [Abstract][Full Text] [Related]
35. Investigations of HBe antigen. Note I. Prevalence of HBeAg and anti-HBe in the stationary phase of HBsAg-positive acute viral hepatitis. Babeş VT; Tănase M; Cepănaru S; Cepănaru R Virologie; 1981; 32(2):93-8. PubMed ID: 6787796 [TBL] [Abstract][Full Text] [Related]
36. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Liaw YF; Chu CM; Lin DY; Sheen IS; Yang CY; Huang MJ J Med Virol; 1984; 13(4):385-91. PubMed ID: 6330293 [TBL] [Abstract][Full Text] [Related]
37. The HBe antigen-antibody system and its relationship to epidemiological, histological and biochemical findings in patients with HBV+ HDV chronic liver diseases. Jelić D; Jelić O Acta Med Croatica; 1994; 48(2):77-83. PubMed ID: 7519502 [TBL] [Abstract][Full Text] [Related]
38. The significance of the HBeAg/anti-HBe system in hemodialysis patients. A multicenter study. Fiaccadori F; David S; Faggion G; Feriani N; Ferrari C; Franco V; Giuberti T; Grutta D'Auria C; La Greca G; Magnani G Infection; 1984; 12(1):23-6. PubMed ID: 6368400 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis B e antigen and antibody measured by radioimmunoassay in acute hepatitis B surface antigen-positive hepatitis. Aldershvile J; Frösner GG; Nielsen JO; Hardt F; Deinhardt F; Skinhøj P J Infect Dis; 1980 Mar; 141(3):293-8. PubMed ID: 7365280 [TBL] [Abstract][Full Text] [Related]
40. [Pathological changes between HBeAg and anti-HBe in patients with chronic hepatitis B]. Xu Q; Shu X; Chen L; Zhou Y; Yao J Zhonghua Gan Zang Bing Za Zhi; 2001 Dec; 9(6):340-2. PubMed ID: 11782300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]